The latest price target for Vyant Bio Inc (OTC:VYNT) was reported by HC Wainwright & Co. on February 3, 2023. The analyst firm set a price target for $0.00 expecting VYNT to fall to within 12 months (a possible -100.00% downside). 0 analyst firms have reported ratings in the last year.

The latest analyst rating for Vyant Bio Inc (OTC:VYNT) was provided by HC Wainwright & Co., and Vyant Bio Inc downgraded their neutral rating.

There is no last upgrade for Vyant Bio Inc

The last downgrade for Vyant Bio Inc happened on February 3, 2023 when HC Wainwright & Co. changed their price target from N/A to N/A for Vyant Bio Inc.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Vyant Bio Inc, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Vyant Bio Inc was filed on February 3, 2023 so you should expect the next rating to be made available sometime around February 3, 2024.

While ratings are subjective and will change, the latest Vyant Bio Inc (VYNT) rating was a downgraded with a price target of $0.00 to $0.00. The current price Vyant Bio Inc (VYNT) is trading at is $0.18, which is out of the analyst’s predicted range.